A patient with fulminant influenza-related bacterial pneumonia due to Streptococcus pneumoniae followed by Mycobacterium tuberculosis infection

Internal Medicine

Volumn 47, Issue 23, 2008, Pages 2043-2047

  Seki, Masafumi ^a,b   Suyama, Naofumi ^c   Hashiguchi, Kohji ^d   Hara, Atsuko ^a   Kosai, Kosuke ^a   Kurihara, Shintaro ^b   Nakamura, Shigeki ^a   Yamamoto, Kazuko ^a,b   Imamura, Yoshifumi ^a,b   Izumikawa, Koichi ^a,b   Kakaya, Hiroshi ^a,b   Yanagihara, Katsunori ^b   Yamamoto, Yoshihiro ^b   Mukae, Hiroshi ^a   Tashiro, Takayoshi ^a,b   Kohno, Shigeru ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nagasaki Municipal Medical Center   (Japan)

^d Nagasaki Atomic Bomb Hospital   (Japan)

Author keywords

Co infection; Influenza virus; Mycobacterium tuberculosis; Pneumonia; Steroid; Streptococcus pneumoniae

Indexed keywords

BIAPENEM; ETHAMBUTOL; ISONIAZID; MEROPENEM; METHYLPREDNISOLONE SODIUM SUCCINATE; OSELTAMIVIR; PYRAZINAMIDE; RIFAMPICIN; SIVELESTAT;

AGED; ARTICLE; CASE REPORT; FATALITY; FEVER; HUMAN; INFLUENZA; INFLUENZA VIRUS A; LUNG TUBERCULOSIS; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NOSE SMEAR; PHAGOCYTOSIS; RESPIRATORY FAILURE; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; URINE CULTURE;

AGED; ANTITUBERCULAR AGENTS; HUMANS; INFLUENZA, HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA, PNEUMOCOCCAL; TUBERCULOSIS, PULMONARY;

EID: 61749099338     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1473     Document Type: Article

References (20)

1. Mandell LA, Wunderink R, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44: S27-S72, 2007.
2. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31: 422-425, 2000.
3. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138-1180, 2005.
4. Glezen WP, Greenberg S, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283: 499-505, 2000.
5. Gerberding JL, Morgan JG, Shapard JO, Kradin RL. An 18-year-old man with respiratory symptoms and shock. N Engl J Med 350: 1236-1247, 2004.
6. Yeldandi AV, Colby T. Pathologic features of lung biopsy specimens from influenza pneumonia cases. Hum Pathol 25: 47-53, 1994.
7. Robertson L, Caley J, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 2: 233-236, 1958.
8. Tashiro M, Ciborowski P, Klenk HD, Pulverer G, Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325: 536-537, 1987.
9. Marcante R, Chiumento F, Palu G, Cavedon G. Rapid diagnosis of influenza type A infection: comparison of shell-vial culture, directigen flu-A and enzyme-linked immunosorbent assay. New Microbiol 19: 141-147, 1996.
10. Mc Cullers JA, Rehg J. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 186: 341-350, 2002.
11. Seki M, Hashiguchi K, Kosai K, et al. A patient with fulminant primary influenza pneumonia which developed into secondary bacterial pneumonia. Acta Medica Nagasakiensia 51: 121-124, 2006.
12. Seki M, Kosai K, Yanagihara K, et al. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern Med 46: 953-958, 2007.
13. Seki M, Yanagihara K, Higashiyama Y, et al. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 24: 143-149, 2004.
14. Seki M, Higashiyama Y, Tomono K, et al. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol 137: 35-40, 2004.
15. Kosai K, Seki M, Yanagihara K, et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand J Infect Dis 4: 1-5, 2007.
16. Kosai K, Seki M, Yanagihara K, et al. Two-dimensional gel electrophoresis analysis in simultaneous influenza pneumonia and bacterial infection in mice. Clin Exp Immunol 152: 364-371, 2008.
17. Kosai K, Seki M, Yanagihara K, et al. Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines. J Int Med Res 36: 322-328, 2008.
18. Opara TN, Gupte C, Liyanage SH, Poole S, Beverly MC. Tuberculous arthritis of the knee with Staphylococcus superinfection. J Bone Joint Surg Br 89: 664-666, 2007.
19. Lin JC, Siu LK, Fung CP, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. Clin Endocrinol Metab 91: 3084-3087, 2006.
20. Kosai K, Seki M, Yanagihara K, et al. Spontaneous pyogenic spondylitis caused by Klebsiella pneumoniae. Intern Med 47: 1121-1124, 2008.